(Q24623768)

12

0 references

Philimon Gona

2

Philimon Gona

0 references

Joseph M Massaro

Joseph M Massaro

4

0 references

Martin G Larson

Martin G Larson

3

0 references

Ramachandran S. Vasan

Ramachandran S Vasan

11

0 references

Udo Hoffmann

9

Udo Hoffmann

0 references

Christopher J O'Donnell

13

Christopher J O'Donnell

0 references

Caroline S. Fox

10

Caroline S Fox

0 references

Wolf Lieb

1

Wolfgang Lieb

0 references

Diane C Corey

8

Diane Corey

0 references

John Keaney

6

John F Keaney

0 references

Izabella Lipinska

5

Izabella Lipinska

0 references

author name string

Jian Rong

Arteriosclerosis, Thrombosis, and Vascular Biology

7

0 references

language of work or name

English

0 references

publication date

September 2010

0 references

published in

0 references

volume

30

0 references

issue

9

0 references

page(s)

1849-54

0 references

cites work

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039214

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039214

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039214

Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039214

Denosumab in men receiving androgen-deprivation therapy for prostate cancer

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039214

Osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand and risk for coronary events: a nested case-control approach in the prospective EPIC-Norfolk population study 1993-2003.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039214

The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039214

Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039214

Soluble RANKL and risk of nontraumatic fracture

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039214

The emerging concept of vascular remodeling

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039214

Serum osteoprotegerin as a biomarker for vascular disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039214

Serum osteoprotegerin as a screening tool for coronary artery calcification score in diabetic pre-dialysis patients

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039214

Parental occurrence of premature cardiovascular disease predicts increased coronary artery and abdominal aortic calcification in the Framingham Offspring and Third Generation cohorts.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039214

Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study).

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039214

Serum osteoprotegerin levels and the extent of vascular calcification in haemodialysis patients

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039214

Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039214

Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039214

Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039214

Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039214

Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease

28 November 2018

1 reference

12 December 2020

Low serum levels of soluble RANK ligand are associated with the presence of coronary artery disease in men

1 reference

12 December 2020

An investigation of coronary heart disease in families. The Framingham offspring study

1 reference

12 December 2020

Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction

1 reference

12 December 2020

Receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) increases vascular permeability: impaired permeability and angiogenesis in eNOS-deficient mice

1 reference

12 December 2020

Soluble receptor activator of nuclear factor-kappa B ligand and risk for cardiovascular disease

1 reference

12 December 2020

Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes

1 reference

12 December 2020

10.1161/ATVBAHA.109.199661

Identifiers

DOI

1 reference

2157084

2157084

1 reference

1 reference

1 reference